CliffBio
small molecule

LUTREPULSE KIT

GONADORELIN ACETATE

Loss of exclusivity—loss of exclusivity
CompanyFerring Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameLUTREPULSE KIT
Active ingredientGONADORELIN ACETATE
Strength0.8MG/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalOctober 1989
Marketing statusDISCN

More from Ferring Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LUTREPULSE KIT patent cliff — loss of exclusivity — | CliffBio